CIK 0001427925
- Non-accelerated filer
- Smaller reporting company
TALPHERA, INC.
Sign in to watch- Ticker
- TLPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 412193603
- Phone
- +1 650-216-3500
- Business address
- 1850 GATEWAY DRIVE, SUITE 175, SAN MATEO, CA, 94404
- Former names
- ACELRX PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-02-06 | Hamel Lawrence G Chief Development Officer | Grant or award | +50,000 | 133,382 | ||
| 2020-02-06 | Hamel Lawrence G Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2019-11-12 | EDWARDS MARK G Director | Purchase | +25,000 | $1.78 | $45K | 243,750 |
| 2019-11-11 | Angotti Vincent J. Chief Executive Officer | Purchase | +8,379 | $1.79 | $15K | 275,944 |
| 2019-11-02 | Palmer Pamela P Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +47,575 | 95,150 | ||
| 2019-11-02 | Dasu Badri N Chief Engineering Officer | Grant or award · Stock Option (Right to Buy) | +31,625 | 63,250 | ||
| 2019-11-02 | Hamel Lawrence G Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +26,125 | 52,250 | ||
| 2019-11-02 | ASADORIAN RAFFI Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +40,563 | 81,125 | ||
| 2019-11-02 | Angotti Vincent J. Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +96,250 | 192,500 | ||
| 2019-08-26 | EDWARDS MARK G Director | Purchase | +5,000 | $2.17 | $11K | 218,750 |
| 2019-08-23 | EDWARDS MARK G Director | Purchase | +10,000 | $2.20 | $22K | 213,750 |
| 2019-06-25 | WAN MARK A Director | Grant or award | +3,750 | 3,750 | ||
| 2019-06-25 | WAN MARK A Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-25 | Rosen Howard B Director | Grant or award | +3,750 | 61,250 | ||
| 2019-06-25 | Rosen Howard B Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-25 | HOFFMAN STEPHEN J Director | Grant or award | +3,750 | 3,750 | ||
| 2019-06-25 | HOFFMAN STEPHEN J Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-25 | Afable Richard Director | Grant or award | +3,750 | 4,750 | ||
| 2019-06-25 | Afable Richard Director | Grant or award · Stock Option (Right to Buy) | +7,500 | 7,500 | ||
| 2019-06-25 | ADAMS ADRIAN Director | Grant or award | +3,750 | 78,750 |
Page 14 of 17 · 329 trades